|
Real-time Estimate
Cboe BZX
04:11:10 01/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 2.070 USD | +15.64% |
|
+22.62% | -60.84% |
| Market Cap | 31.48M 27.73M 26.27M 23.71M 44.7M 3.02B 45.27M 314M 121M 1.54B 118M 116M 4.95B | P/E 2026 * |
-0.58x | P/E 2027 * | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | 25.93M 22.83M 21.63M 19.53M 36.81M 2.49B 37.29M 259M 99.61M 1.27B 97.37M 95.24M 4.07B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 4.38x |
| Free-Float |
96.32% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CVM | Delayed | |
CBOE
| CVM | Real-time | |
|
Deutsche Boerse AG
| LSR | Delayed | |
|
Boerse Muenchen
| LSR | Real-time |
| 19/07/23 | Wall Street sluit hoger | |
| 19/07/23 | Wall Street op winst | |
| 18/07/23 | Wall Street richting licht rode opening | |
| 18/07/23 | Futures voorspellen terughoudende opening Wall Street | |
| 29/06/21 | Cel-Sci presenteert positieve onderzoeksdata immunotherapie |
| 1 day | +14.80% | ||
| 1 week | +22.62% | ||
| Current month | +27.16% | ||
| 1 month | +27.16% | ||
| 3 months | +98.08% | ||
| 6 months | -32.90% | ||
| Current year | -60.84% |
| 1 week | 1.66 |  | 2.09 |
| 1 month | 1.46 | | 2.09 |
| Current year | 0.89 | | 6.75 |
| 1 year | 0.89 | | 10.83 |
| 3 years | 0.89 | | 96.91 |
| 5 years | 0.89 | | 384.64 |
| 10 years | 0.89 | | 1,227.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
Geert Kersten
CEO | Chief Executive Officer | 67 | 01/01/1995 |
Patricia Prichep
DFI | Director of Finance/CFO | 75 | 13/11/2024 |
| Chief Tech/Sci/R&D Officer | - | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Geert Kersten
BRD | Director/Board Member | 67 | 01/01/1995 |
| Director/Board Member | 73 | 22/06/2015 | |
Bob Watson
CHM | Chairman | 69 | 08/07/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/8/26 | Buy | Chief Executive Officer | 100,000 | 0.5722% | ||
| 14/8/26 | Free | Chief Financial Officer | 225,000 | 1.2874% | ||
| 14/8/26 | Free | Director | 110,000 | 0.6294% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +13.97% | +22.62% | -77.61% | -94.08% | 31.48M | |
| +4.16% | -0.30% | +58.96% | +94.17% | 71.53B | |
| -0.19% | +1.32% | +37.20% | +81.33% | 60.12B | |
| -1.51% | +2.39% | +9.10% | +36.79% | 48.85B | |
| +1.06% | +1.11% | +42.59% | +39.69% | 44.28B | |
| +1.67% | +8.68% | +343.88% | +692.09% | 43.83B | |
| +1.96% | +2.13% | +9.42% | +108.84% | 41.53B | |
| -0.67% | -0.45% | +4.47% | +46.37% | 30.13B | |
| +4.77% | +6.46% | +41.54% | +22.78% | 27.98B | |
| +0.60% | -2.37% | -19.78% | +355.38% | 25.25B | |
| Average | +2.69% | +0.96% | +44.98% | +138.34% | 39.35B | |
| Weighted average by Cap. | +1.41% | +0.63% | +63.63% | +155.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5.97M 5.26M 4.98M 4.5M 8.48M 573M 8.59M 59.61M 22.94M 293M 22.42M 21.94M 939M |
| Net income | -25.08M -22.09M -20.93M -18.89M -35.61M -2.41B -36.07M -250M -96.36M -1.23B -94.19M -92.14M -3.94B | -29.51M -25.99M -24.62M -22.23M -41.9M -2.83B -42.44M -295M -113M -1.45B -111M -108M -4.64B |
| Net Debt | -5.55M -4.89M -4.63M -4.18M -7.88M -533M -7.99M -55.44M -21.34M -272M -20.86M -20.4M -873M | -5.34M -4.7M -4.45M -4.02M -7.58M -512M -7.68M -53.3M -20.51M -262M -20.05M -19.61M -839M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | USD 2.060 | +15.08% | 374,166 |
| 29/09/26 | USD 1.790 | +5.29% | 75,217 |
| 28/09/26 | USD 1.700 | +1.80% | 126,230 |
| 25/09/26 | USD 1.670 | -2.91% | 36,410 |
| 24/09/26 | USD 1.720 | +2.38% | 56,130 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CVM Stock
Select your edition
All financial news and data tailored to specific country editions
